CFB PAE02 Child Growth And Development
Child growth and development encompasses the progressive physical, cognitive, emotional, and social maturation from infancy through adolescence, assessed through standardized milestones and growth parameters.
Child Growth and Development
This lecture by Dr Queenie See (CFB PAE02) covers the full spectrum of normal and abnormal physical growth in children. It is a foundational paediatrics lecture that underpins your approach to any child presenting with growth concerns. The big idea is: growth is the single best indicator of a child's overall health, and deviation from normal growth patterns is often the first sign of underlying disease.
Learning objectives (derived from lecture scope):
- Understand determinants of normal growth (genetic, hormonal, nutritional, environmental)
- Know normal weight, height, and head circumference milestones
- Calculate mid-parental height and interpret growth charts
- Understand normal puberty timing and its effect on growth
- Define and classify short stature and tall stature
- Systematically categorize causes using the "4 major groups" framework
- Know the PICNICS mnemonic for pathological short stature
- Recognize syndromal, disproportionate, and endocrine causes
- Define overweight and obesity in children
- Approach investigations and management
Exam relevance: This lecture is directly examined in MCQs (e.g., 2024 Q92 tested Turner syndrome recognition in a short girl with webbed neck; 2025 Q77 tested Turner syndrome vs Noonan vs achondroplasia) and SAQs (2016 Q10 asked about parameters for general well-being of a child). Growth chart interpretation, mid-parental height calculation, and the "4 major groups" classification are perennial favourites.
Core Concepts and Mechanisms
Growth is not just "getting bigger." It reflects the integrated function of genetics, hormones, nutrition, organ systems, and psychosocial well-being. A child who stops growing or deviates from their expected trajectory is essentially telling you something is wrong—long before other symptoms appear. This is why serial plotting on growth charts is the single most important surveillance tool in paediatrics.
Growth is an orchestrated network of control—it cannot be too much, cannot be too little, and must happen at the right time and right place. [1]
Size is determined by:
- Genetic potential – parental heights set the "target"
- Hormonal milieu – GH, thyroid hormone, sex steroids, cortisol, insulin/IGF-1
- Nutrition – calories, protein, micronutrients
- Health/disease – chronic illness diverts energy from growth
- Psychosocial environment – deprivation and stress suppress GH secretion
| Phase | Age Range | Growth Velocity | Key Determinants | Contribution to Final Height |
|---|---|---|---|---|
| Fetal | Conception – birth | ~60 cm/year | Placental function, maternal nutrition/health, smoking | ~30% |
| Infantile | Birth – 2 years | ~25 cm/year (decelerating) | Nutrition, health, thyroid hormone | ~15% |
| Childhood | 2 years – puberty | ~5 cm/year (constant) | GH, nutrition, health | ~40% |
| Pubertal | Puberty onset – epiphyseal fusion | ~10 cm/year at peak | Sex steroids (testosterone, estradiol), GH | ~15% |
Why this matters: In the fetal phase, genetics play a smaller role than maternal/placental factors—a large genetic father can have a small baby if the mother is small or malnourished. After birth, the child "catches up" or "catches down" to their genetic potential over the first 2 years. After age 2, deviation from centiles is more concerning because growth should be tracking steadily.
Normal Growth: Slide-by-Slide High-Yield Content
Normal growth is the progression of changes in weight, height, and head circumference that are compatible with established standards for a given population, reflecting genetic potentials and environmental factors, with adequate lengthening of the skeleton. [1]
A newborn's size is determined by the intrauterine environment—influenced by maternal size, nutrition, general health, and social habits (e.g., smoking status). [1]
This is why birth weight correlates more with maternal size than paternal size. A genetically tall baby born to a small mother will be constrained in utero but will "catch up" postnatally.
Growth velocity is greatest in late fetal life, then peaks again during puberty, and eventually decreases when oestrogen-mediated epiphyseal fusion occurs in adolescence. [1]
Key point: It is oestrogen (not testosterone) that causes epiphyseal fusion in both sexes. Boys grow taller than girls partly because they enter puberty ~2 years later, giving them more years of pre-pubertal growth at ~5 cm/year.
Growth rates are similar between genders until puberty. Males have a later pubertal growth spurt and higher velocity during the spurt. [1]
Hong Kong-specific data (exam-worthy):
50th centile adult height: Male = 171 cm, Female = 158 cm in Hong Kong. [1]
| Period | Weight Gain Rate | Key Milestone |
|---|---|---|
| First few days | May lose up to 10% of birth weight | Physiological weight loss (fluid shifts) |
| Day 10–14 | Regain birth weight | |
| 0–3 months | ~30 g/day | |
| 3–6 months | ~20 g/day | Double birth weight by 4 months |
| 6–12 months | ~10 g/day | Triple birth weight by 1 year |
| ≥ 2 years | ~2 kg/year until puberty |
Why Do Neonates Lose Weight?
In the first few days, the neonate loses extracellular fluid accumulated in utero. This is normal up to 10% of birth weight. Beyond 10% is pathological and suggests feeding difficulty, dehydration, or illness. Breastfed infants may take slightly longer to regain birth weight than formula-fed infants, but should still regain by 10–14 days.
Average length at birth for a term infant is 50 cm (20 inches). [1]
| Period | Growth | Notes |
|---|---|---|
| First year | 25 cm | Fastest postnatal growth |
| 12–24 months | 10 cm | |
| 24–36 months | 7.5 cm | |
| 36–48 months | 7.5 cm | |
| 4 years – puberty | 5 cm/year | Steady "childhood" phase |
| Pre-pubertal | Normal deceleration before pubertal spurt | Don't mistake this for pathology! |
Children reach one-half of their adult height by 24 to 30 months. [1]
This is a useful clinical rule. Example from the lecture: Ethan is 86 cm at 24 months → predicted adult height ≈ 86 × 2 = 172 cm.
Boy = (father's height + mother's height + 13) ÷ 2 Girl = (father's height + mother's height − 13) ÷ 2 [1]
The ±13 cm adjusts for the average height difference between adult males and females. The target range is MPH ± 8.5 cm (approximately 3rd to 97th centile for that family).
Example from lecture:
Ethan: Mother 164 cm, Father 170 cm → MPH = (164 + 170 + 13)/2 = 173 cm [1]
Common Exam Trap
Some students use +12 instead of +13 (or vice versa). The CFB lecture uses +13 / −13. Maksim's Paediatric Notes use +12/−12. For the HKUMed exam, use the lecture value of ±13. If a question gives you the formula, use whatever they give.
Though not heavily detailed in this lecture, head circumference is the third key growth parameter. It reflects brain growth. In failure to thrive, weight drops first, then height, with relative sparing of head circumference (the body protects brain growth). If head circumference is disproportionately affected, think of a primary neurological/genetic problem rather than nutritional failure.
Onset of puberty: Girls generally 8–12 years; Boys generally 9–14 years. [1]
| Feature | Girls | Boys |
|---|---|---|
| First sign | Breast development (thelarche) | Testicular enlargement (≥4 mL) |
| Other features | Widening of hips, menstruation | Penis enlargement, deepening of voice, increased muscle mass |
| Common to both | Pubic hair, axillary hair, body odour, pimples | |
| Peak growth spurt | ~10 years old | ~12 years old |
Why girls are shorter: Girls enter puberty earlier → earlier peak growth spurt → earlier epiphyseal fusion → less total years of growth. Boys get ~2 extra years of pre-pubertal growth at 5 cm/year (= ~10 cm extra) PLUS a higher peak velocity.
Short Stature
Short stature is defined as a height that is 2 standard deviations (SD) or more below the mean height for individuals of the same sex and chronologic age in a given population. This translates to a height below the 2nd percentile. [1]
Note: Some sources use the 3rd percentile as the cutoff. The lecture uses 2nd percentile (= −2 SD). For the exam, go with the lecture definition.
1. How short is the child? 2. Is the child's height velocity impaired? 3. What is the child's predicted adult height? [1]
Height velocity is more important than a single height measurement. A child on the 5th centile who is growing at a normal velocity along that centile is likely a normal variant. A child on the 25th centile whose growth is crossing downward is more concerning.
P – Psychological deprivation I – Iatrogenic (glucocorticoids, spinal radiation) C – Chronic illness N – Nutritional I – IUGR (unknown aetiology or part of a syndrome, e.g., Russell-Silver syndrome) C – Chromosomal (Turner, Noonan, Down, Prader-Willi) S – Skeletal dysplasia (achondroplasia, hypochondroplasia) [1]
Plus Endocrine causes: hypothyroidism, GH deficiency, Cushing syndrome.
This is the lecture's core clinical classification and is extremely high-yield:
1. Dysmorphism with a recognizable syndrome 2. Disproportionate short stature – usually needs a skeletal survey 3. Short but thin – search for chronic illness 4. Short and fat – more suggestive of an endocrine cause [1]
High-Yield Clinical Logic
Short and thin = the body is using up its reserves (wasting) → chronic illness, malabsorption, malnutrition. Weight centile drops BEFORE height centile.
Short and fat = the endocrine problem is causing both poor linear growth AND weight gain. GH deficiency, hypothyroidism, and Cushing syndrome all cause this pattern because cortisol/thyroid dysfunction promotes fat deposition while impairing bone growth.
Body height < 1st centile; abnormally short for family heights; history or examination suggestive of chronic illness; abnormal growth velocity; abnormal body proportions; dysmorphic features or midline defects. [1]
Detailed Causes of Short Stature
Group 1: Dysmorphism with a Recognizable Syndrome
- Most common chromosomal cause of intellectual disability
- Features: flat facial profile, upslanting palpebral fissures, epicanthal folds, Brushfield spots, single palmar crease, clinodactyly, sandal gap, hypotonia
- Growth: short stature (specific Down syndrome growth charts exist)
- Associated: congenital heart disease (AVSD most characteristic), duodenal atresia, Hirschsprung disease, hypothyroidism, atlantoaxial instability
Female with complete or partial absence of one X chromosome may have features including short stature, broad chest, widely spaced nipples, webbed neck, increased carrying angle (cubitus valgus), and other system disorders such as cardiac defects, renal anomalies, and hypothyroidism. [1]
This is the single most commonly tested syndromal cause of short stature in HKUMed exams. The 2024 MCQ Q92 and 2025 MCQ Q77 both tested this directly [3][4].
| Feature | Why It Happens |
|---|---|
| Short stature | SHOX gene haploinsufficiency on Xp (short arm) |
| Webbed neck | Cystic hygroma that resolved in utero |
| Shield chest / widely spaced nipples | Skeletal abnormality |
| Cubitus valgus | Skeletal abnormality |
| Cardiac defects (bicuspid aortic valve, coarctation) | Developmental |
| Streak gonads / primary amenorrhoea | Gonadal dysgenesis |
| Hypothyroidism | Autoimmune association |
| Renal anomalies (horseshoe kidney) | Developmental |
Investigations must include karyotype in ALL girls with unexplained short stature – this is explicitly stated in the lecture.
Hypertelorism, downward slanting eyes, low-set/abnormally shaped/posteriorly rotated ears, short stature, broad or webbed neck, heart defects (HOCM, ASD, VSD, pulmonary stenosis), vision and hearing problems, abnormal bleeding/bruising, unusual chest shape (sunken or protruding – pectus excavatum/carinatum), mild developmental delay/intellectual disability. [1]
Turner vs Noonan – Exam Discriminator
Both have short stature, webbed neck, and cardiac defects. Key differences:
- Turner: Female only (45,X); coarctation of aorta / bicuspid aortic valve; streak gonads; SHOX-related; cubitus valgus; Madelung deformity
- Noonan: Both sexes; autosomal dominant (RAS-MAPK pathway); pulmonary stenosis and HOCM are the characteristic cardiac lesions; cryptorchidism in males; bleeding diathesis; downslanting eyes (vs upslanting in Down)
The 2025 Q77 tested exactly this: girl with webbed neck, shield chest, cubitus valgus, Madelung deformity, BP 135/65 → Turner (the widened pulse pressure hints at coarctation). Answer is Turner, NOT Noonan.
- IUGR / SGA with failure of catch-up growth
- Triangular face, frontal bossing, clinodactyly of 5th finger
- Body asymmetry (hemihypertrophy or hemihypotrophy)
- Feeding difficulties in infancy
- Genetic: 11p15 imprinting disorder or maternal UPD7
Group 2: Disproportionate Short Stature
Key principle: Measure body proportions (arm span, upper segment:lower segment ratio). If proportions are abnormal, you need a skeletal survey.
- Spondyloepiphyseal dysplasia: disproportionately short trunk, kyphoscoliosis
- Mucopolysaccharidosis (MPS): progressive multisystemic lysosomal storage disorder
MPS is a progressive multisystemic disorder. Extra-skeletal: umbilical/inguinal hernia, valvular heart disease, obstructive airway disease, corneal clouding, hepatosplenomegaly, chronic rhinitis/otitis, developmental delay, hearing loss, enlarged tongue, skin thickening. [1]
Skeletal: joint contracture without inflammation, cervical spine stenosis/cord compression, pectus carinatum, kyphosis/scoliosis, bilateral hip dysplasia, genu valgum, waddling gait, short stature, idiopathic carpal tunnel syndrome, multiple joint pain. [1]
Facial features: Broad nose, flat nasal bridge, prominent eyes, enlarged tongue and lips, prominent forehead, macrocephaly, coarse hair.
Why recognize MPS? It is treatable (enzyme replacement therapy for some subtypes) and early diagnosis changes outcomes. Joint contractures without inflammation should raise suspicion.
Achondroplasia:
Autosomal dominant – FGFR3 mutation. Short stature at birth. Rhizomelic shortening. Head disproportionately large. Thoracolumbar kyphosis (gibbus). Trident hand with brachydactyly. [1]
FGFR3 is a negative regulator of bone growth. The gain-of-function mutation makes it constitutively active → excessive inhibition of chondrocyte proliferation at the growth plate → short long bones. Most cases are de novo mutations.
Hypochondroplasia:
Short-limbed short stature with considerable shortening and marked bowing of legs. In contrast to achondroplasia, the head size and facial features are normal. [1]
Also FGFR3 mutation but milder.
Trident hand: Short digits, wide hands. The hand resembles a trident consisting of the thumb, 2nd–3rd fingers, and 4th–5th fingers. Seen in both achondroplasia and hypochondroplasia.
Search for associated chronic disease: cardiovascular disease, respiratory disease (cystic fibrosis), malabsorption/chronic inflammatory bowel disease, chronic renal failure, psychosocial deprivation, anorexia nervosa. [1]
Also: rickets (chronic renal failure → vitamin D deficiency → poor bone mineralization) and thalassaemia (chronic anaemia, iron overload, endocrine dysfunction from haemosiderosis).
Why short AND thin? The chronic illness consumes energy reserves → weight drops first (thin), then linear growth suffers (short). This is the opposite pattern to endocrine causes.
More suggestive of endocrine cause: panhypopituitarism, isolated growth hormone deficiency, hypothyroidism, pseudohypoparathyroidism, Cushing's syndrome, Prader-Willi syndrome. [1]
Why short AND fat?
- GH deficiency: GH promotes lipolysis and linear growth. Without it, fat accumulates and bones don't grow.
- Hypothyroidism: Thyroid hormone is essential for normal bone maturation and metabolism. Low TH → slow metabolism (fat gain) + delayed bone age (short).
- Cushing's syndrome: Excess cortisol promotes central adiposity and inhibits GH secretion and growth plate activity.
- Prader-Willi syndrome: Hyperphagia from hypothalamic dysfunction + GH deficiency → extreme obesity with short stature.
Two normal variants: Familial short stature and Constitutional delay. [1]
| Feature | Familial Short Stature | Constitutional Delay |
|---|---|---|
| Parents | Short | Normal or family history of late puberty |
| Growth velocity | Normal | Normal (but delayed) |
| Bone age | = Chronological age | < Chronological age (delayed) |
| Puberty | Normal timing | Delayed |
| Final adult height | Short (within MPH range) | Normal (catches up) |
| MPH | Low | Normal |
Maternal pregnancy history, birth and perinatal history, birth weight/length; Onset and duration of catch-up or catch-down growth; Serial height measurements on a growth chart, prepubertal and pubertal growth velocity; Nutritional history; Family heights and maturational history; MPH (range: ±8.5 cm); Family history of delayed growth and pubertal development; Systems review for chronic illness; Psychosocial history. [1]
Accurate measurement of body height, weight, and head circumference; Body proportions (arm span, upper segment to lower segment ratio); Dysmorphism; Dentition and other midline defects; Visual fields and fundoscopic examination; Thyroid assessment; Specific systems. [1]
Why visual fields? A pituitary/hypothalamic tumour (e.g., craniopharyngioma) causing GH deficiency may compress the optic chiasm → bitemporal hemianopia. Midline defects (e.g., cleft lip/palate, single central incisor) may be associated with septo-optic dysplasia or other midline brain anomalies causing hypopituitarism.
CBP, ESR, L/RFT, electrolytes, bone profile, thyroid function, IGF-1; Bone age; Karyotype in girls; Provocative growth hormone testing. [1]
| Investigation | What It Tells You |
|---|---|
| CBP, ESR | Chronic inflammation, anaemia, malignancy |
| LFT, RFT | Chronic liver/renal disease |
| Electrolytes, bone profile | Renal tubular acidosis, rickets, pseudohypoparathyroidism |
| TFT | Hypothyroidism |
| IGF-1 | Screening for GH deficiency (low IGF-1 suggests GHD) |
| Bone age (X-ray left wrist) | Delayed = constitutional delay or hypothyroidism; Advanced = precocious puberty |
| Karyotype (girls) | Turner syndrome – MUST do in all short girls |
| Provocative GH testing | Insulin tolerance test (gold standard) or glucagon test – confirms GH deficiency if GH fails to rise above threshold |
Why Karyotype in Girls?
Turner syndrome can present with very subtle phenotypes (mosaic forms). A girl with unexplained short stature and no obvious dysmorphic features could still have Turner syndrome. Missing this diagnosis means missing cardiac surveillance, growth hormone treatment opportunity, and fertility counselling. Always karyotype.
Depends on underlying cause: - GH deficiency → GH replacement - Hypothyroidism → thyroid hormone replacement - Ensure adequate nutrition - Explanation and reassurance if non-pathological - Explore issues around school, sport, and family to help encourage short children to feel comfortable with their height outcome - Regular check-ups to monitor growth - Referral to paediatric endocrinologist if pathological cause suspected [1]
Tall Stature
A far less common presenting problem than short stature. The vast majority have familial tall stature. [1]
Serial measurements to determine duration and plotting against parents' heights is important. Those children 'crossing centiles' are more likely to have an underlying pathological basis. [1]
Investigations: TFT, IGF-1, karyotype, bone age.
- Tall parents, may have family history of early puberty
- Bone age may show advancement → helps predict final height
Hyperthyroidism; Precocious puberty (tall at diagnosis but reduced final height due to premature fusion of epiphyses); GH-secreting tumours (extremely rare in paediatrics). [1]
Why is precocious puberty a cause of TALL stature initially but SHORT final height? Early puberty → early sex steroid exposure → early growth spurt (child is temporarily tall for age) → but also early epiphyseal fusion → growth stops prematurely → reduced adult height.
| Syndrome | Key Features |
|---|---|
| Klinefelter (47,XXY) | Tall stature, eunuchoid body habitus, poor musculature, sparse body/facial hair, small testes, aggressive impulsive personality |
| Marfan syndrome | AD, fibrillin gene defect; hyperextensibility, arachnodactyly, kyphoscoliosis, aortic root problems, lens dislocation, high arch palate. MEN IIB has a similar phenotype |
| Sotos syndrome | Cerebral gigantism; rapid growth in early childhood |
| Homocystinuria | AR; Marfan-like phenotype + poor bone density + increased thrombosis tendency |
| Beckwith-Wiedemann syndrome | Fetal overgrowth: macrosomia, macroglossia, hepatosplenomegaly, hypoglycaemia, risk of Wilms' tumour |
Marfan vs Homocystinuria – Exam Discriminator
Both are tall with Marfanoid habitus. Key differences:
- Marfan: AD, lens dislocation is superotemporal (UP), aortic root dilatation, NO thrombosis
- Homocystinuria: AR, lens dislocation is inferonasal (DOWN), osteoporosis, thromboembolism, intellectual disability
Overweight and Obesity
BMI is the widely accepted standard measure of overweight and obesity for children ≥ 2 years. [1]
Adult WHO cut-offs:
Overweight: BMI > 25 (Asian > 23); Obesity: BMI > 30 (Asian > 25) [1]
Paediatric definition (age- and sex-specific BMI charts):
Overweight: ≥ 1 SD above mean BMI for age and sex Obesity: ≥ 2 SD above mean BMI for age and sex [1]
Note: In children, absolute BMI numbers change with age, so we use centiles/SD scores on age-sex-specific BMI charts rather than fixed thresholds.
Genetics/Epigenetics, Early life events, Biology, Environment, Stress, Behaviour [1]
Most childhood obesity is exogenous (energy intake > expenditure). Endocrine/genetic causes (e.g., hypothyroidism, Cushing, Prader-Willi) are rare but must be excluded if the child is also short—remember the "short and fat" group points toward endocrine pathology.
Metabolic syndrome prevalence: normal weight adolescents 0–4.7% vs obese 14.5–35%; 1/3 of children with NAFLD had T2DM or prediabetes; Adolescents with severe obesity may have more advanced liver damage than adults; Pediatric T2DM has more rapid β-cell failure than adults; Obese young-onset T2DM has very high mortality rate. [1]
High-Yield: Pediatric Obesity Consequences
Childhood obesity is NOT benign. It tracks into adulthood and accelerates metabolic disease. Paediatric NAFLD may be MORE aggressive than adult NAFLD. Young-onset T2DM has faster β-cell failure and higher mortality than adult-onset T2DM. This is why early intervention matters.
- GC 149 (Premature Puberty): Precocious puberty causes tall stature initially but short final height. Assessment includes Tanner staging, bone age, LH/FSH, sex steroids, brain MRI [5].
- GC 150 (The Child is Too Thin): Nutritional deficiency states cause the "short but thin" pattern. Growth is a dynamic process relative to norms [6].
- GC 151 (The Malformed Child): Syndromal causes of short/tall stature overlap heavily with this lecture.
- Developmental Milestones (Dr Tso's table): Growth assessment is separate from developmental assessment but they are examined together. Know both.
- Congenital hypothyroidism [7]: Neonatal cord blood TSH screening; local incidence 1:3000. If missed → cretinism, mental retardation, short stature. Caught early → normal development with thyroxine replacement.
Likely Exam Questions
-
A 5-year-old girl is found to be below the 2nd centile for height. She has a webbed neck, shield chest, and wide-spaced nipples. What is the most likely diagnosis? → Turner syndrome (karyotype 45,X)
-
A child is short and overweight with delayed bone age. What is the most likely category of cause? → Endocrine (short and fat)
-
What investigation must be performed in ALL girls with unexplained short stature? → Karyotype
-
By what age do infants double their birth weight? → 4 months. Triple? → 1 year.
-
A 2-year-old boy is 86 cm. What is his estimated adult height? → 86 × 2 = 172 cm
2016 Q10: "What parameters obtained during physical examination could be used as an indicator of the general well-being of a child?" [8]
- Answer: Weight, height/length, head circumference, BMI, body proportions, growth velocity (serial measurements on growth chart), pubertal staging, nutritional status, dysmorphic features assessment
Possible SAQ: "A 10-year-old girl is referred for short stature. Height is below the 1st centile. Parents are of normal height. Outline your approach."
- Markscheme: History (pregnancy, birth weight, growth velocity, nutritional, family heights/MPH, systems review, psychosocial); Examination (accurate measurements, proportions, dysmorphism, midline defects, visual fields, thyroid); Investigations (CBP, ESR, LFT, RFT, electrolytes, bone profile, TFT, IGF-1, bone age, KARYOTYPE); Classify into 4 groups; Manage underlying cause; Refer to paediatric endocrinologist.
| Trap | Correct Answer |
|---|---|
| Using BMI > 25 for paediatric obesity | Use age/sex-specific BMI charts (≥ 2 SD above mean) |
| Forgetting karyotype in short girls | ALWAYS do karyotype – Turner can be subtle |
| Confusing constitutional delay with familial short stature | Constitutional = delayed bone age + delayed puberty + normal final height; Familial = normal bone age + normal puberty + short final height |
| Thinking precocious puberty = short stature | Initially TALL, but reduced FINAL height |
| Noonan = females only | Noonan affects BOTH sexes (unlike Turner) |
| Achondroplasia = AR | Achondroplasia = Autosomal DOMINANT (FGFR3) |
High Yield Summary
Normal Growth: Birth weight doubles by 4 months, triples by 1 year. Birth length 50 cm, grows 25 cm in first year, then 5 cm/year until puberty. Half adult height reached by 24–30 months. MPH formula: Boy = (F+M+13)/2; Girl = (F+M−13)/2; range ±8.5 cm.
Short Stature Definition: < 2 SD below mean (< 2nd centile). Most important: growth velocity, not single measurement.
4 Groups: (1) Dysmorphic syndromes (Down, Turner, Noonan, Russell-Silver); (2) Disproportionate (achondroplasia, MPS, SED); (3) Short+thin = chronic illness; (4) Short+fat = endocrine.
PICNICS: Psychological, Iatrogenic, Chronic illness, Nutritional, IUGR, Chromosomal, Skeletal dysplasia + Endocrine.
Must-do investigations: CBP/ESR/LFT/RFT/electrolytes/bone profile/TFT/IGF-1/bone age. KARYOTYPE in ALL SHORT GIRLS.
Normal variants: Familial short stature (bone age = chronological age) vs Constitutional delay (bone age < chronological age, delayed puberty, normal final height).
Tall stature syndromes: Klinefelter (47,XXY), Marfan, Sotos, Homocystinuria, Beckwith-Wiedemann.
Obesity: Paediatric BMI ≥ 2 SD = obesity. Childhood obesity → aggressive NAFLD, early T2DM with rapid β-cell failure, high mortality.
Puberty: Girls 8–12 (breast first, peak growth ~10y); Boys 9–14 (testes first, peak growth ~12y). Oestrogen causes epiphyseal fusion in BOTH sexes.
Active Recall - Child Growth and Development
[1] Lecture slides: CFB (PAE02) Child growth and development.pdf [2] Senior notes: Adrian Lui Pediatrics Notes.pdf (Chapter 3.1 Growth and Pubertal Disorders) [3] Past papers: 2024 Fourth Summative MCQ.pdf (Q92) [4] Past papers: 2025 Fourth Summative MCQ.pdf (Q77) [5] Lecture slides: GC 149. Premature puberty puberty and related disorders.pdf [6] Lecture slides: GC 150. The child is too thin nutrition and growth, nutritional deficiency states.pdf [7] Senior notes: Block A - I am losing weight and sweating all the time_ causes of severe, weight loss; thyrotoxicosis; hypothyroidism.pdf (Congenital hypothyroidism section) [8] Past papers: 2016 Fourth Summative SAQ.pdf (Q10)
CFB MED04 Central Nervous System
The central nervous system comprises the brain and spinal cord, serving as the primary integration and command center for processing sensory information, coordinating motor output, and governing higher cognitive functions.
CFB OT02 Childrens Orthopaedics And Deformities
A pediatric orthopedic subspecialty focused on the diagnosis and management of congenital, developmental, and acquired musculoskeletal deformities in children, including conditions such as clubfoot, limb length discrepancies, angular deformities, and skeletal dysplasias.